Astrazeneca Plc (AZN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,143,000 | 7,058,000 | 5,230,000 | 5,488,000 | 4,797,000 |
| Marketable Securities | 39,000 | 50,000 | 165,000 | 166,000 | 133,000 |
| Inventories | 6,593,000 | 6,467,000 | 5,884,000 | 5,288,000 | 5,662,000 |
| Other current assets | 15,165,000 | 15,364,000 | 14,860,000 | 14,885,000 | 13,563,000 |
| TOTAL | $29,940,000 | $28,939,000 | $26,139,000 | $25,827,000 | $24,155,000 |
| Non-Current Assets | |||||
| PPE Net | 13,783,000 | 13,229,000 | 12,303,000 | 11,647,000 | 11,513,000 |
| Intangibles | 59,410,000 | 59,147,000 | 58,680,000 | 58,202,000 | 60,533,000 |
| Other Non-Current Assets | 11,323,000 | 11,107,000 | 9,131,000 | 8,359,000 | 8,721,000 |
| TOTAL | $84,516,000 | $83,483,000 | $80,114,000 | $78,208,000 | $80,767,000 |
| Total Assets | $114,456,000 | $112,422,000 | $106,253,000 | $104,035,000 | $104,922,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,174,000 | 6,492,000 | 3,051,000 | 2,156,000 | 1,253,000 |
| Accounts payable and accrued liabilities | 25,028,000 | 23,986,000 | 22,544,000 | 22,465,000 | 21,684,000 |
| TOTAL | $34,054,000 | $33,536,000 | $29,129,000 | $27,866,000 | $25,926,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 24,700,000 | 24,714,000 | 26,692,000 | 26,506,000 | 28,887,000 |
| Other Non-Current Liabilities | 4,665,000 | 4,384,000 | 4,460,000 | 4,289,000 | 4,545,000 |
| TOTAL | $34,431,000 | $34,076,000 | $35,993,000 | $35,298,000 | $38,191,000 |
| Total Liabilities | $68,485,000 | $67,612,000 | $65,122,000 | $63,164,000 | $64,117,000 |
| Shareholders' Equity | |||||
| Common Shares | 388,000 | 388,000 | 388,000 | 388,000 | 388,000 |
| Retained earnings | 8,213,000 | 7,023,000 | 3,364,000 | 3,160,000 | 3,138,000 |
| Other shareholders' equity | 2,044,000 | 2,070,000 | 2,054,000 | 2,012,000 | 1,990,000 |
| TOTAL | $45,888,000 | $44,719,000 | $41,039,000 | $40,786,000 | $40,719,000 |
| Total Liabilities And Equity | $114,373,000 | $112,331,000 | $106,161,000 | $103,950,000 | $104,836,000 |